| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
| 1 | Arachidonic acid metabolism 2 genes, 1 drug (DrugBank) and 10 diseases shown |
2件: PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 2 | C-type lectin receptor signaling pathway 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 3 | Chemical carcinogenesis 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 4 | Cytokine-cytokine receptor interaction 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 5 | GABAergic synapse 16 genes, 1 drug (DrugBank) and 8 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 6 | Hematopoietic cell lineage 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 7 | Human cytomegalovirus infection 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 8 | Human papillomavirus infection 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 9 | IL-17 signaling pathway 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 10 | JAK-STAT signaling pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 11 | Kaposi sarcoma-associated herpesvirus infection 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 12 | Leishmaniasis 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 13 | Metabolic pathways 2 genes, 1 drug (DrugBank) and 10 diseases shown |
2件: PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 14 | MicroRNAs in cancer 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 15 | Morphine addiction 16 genes, 1 drug (DrugBank) and 8 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 16 | Neuroactive ligand-receptor interaction 16 genes, 1 drug (DrugBank) and 8 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 17 | NF-kappa B signaling pathway 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 18 | Nicotine addiction 16 genes, 1 drug (DrugBank) and 8 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 19 | Ovarian steroidogenesis 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 20 | Oxytocin signaling pathway 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 21 | Pathways in cancer 2 genes, 2 drugs (DrugBank) and 16 diseases shown |
1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 22 | PI3K-Akt signaling pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 23 | Platelet activation 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS1 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 24 | Regulation of lipolysis in adipocytes 2 genes, 1 drug (DrugBank) and 10 diseases shown |
2件: PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 25 | Retrograde endocannabinoid signaling 17 genes, 2 drugs (DrugBank) and 15 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 26 | Serotonergic synapse 5 genes, 2 drugs (DrugBank) and 15 diseases shown |
3件: GABRB1, GABRB2, GABRB3 |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 2件: PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 27 | Small cell lung cancer 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 28 | Taste transduction 6 genes, 1 drug (DrugBank) and 8 diseases shown |
6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 29 | TNF signaling pathway 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 30 | VEGF signaling pathway 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: PTGS2 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |